Your browser doesn't support javascript.
loading
Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas.
Holdhoff, Matthias; Nicholas, M Kelly; Peterson, Richard A; Maraka, Stefania; Liu, Li C; Fischer, James H; Wefel, Jeffrey S; Fan, Timothy M; Vannorsdall, Tracy; Russell, Meredith; Iacoboni, Michaella; Tarasow, Theodore M; Hergenrother, Paul J; Dudek, Arkadiusz Z; Danciu, Oana C.
Afiliación
  • Holdhoff M; Department of Oncology, Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.
  • Nicholas MK; Department of Neurology and Rehabilitation, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Peterson RA; HealthPartners Institute, Regions Cancer Care Center, St. Paul, Minnesota, USA.
  • Maraka S; Department of Neurology and Rehabilitation, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Liu LC; Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Fischer JH; Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Wefel JS; Department of Neuro-Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
  • Fan TM; Vanquish Oncology, Inc., Champaign, Illinois, USA.
  • Vannorsdall T; Department of Veterinary Clinical Medicine, University of Illinois, Urbana-Champaign, Illinois, USA.
  • Russell M; Cancer Center at Illinois, Urbana-Champaign, Illinois, USA.
  • Iacoboni M; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Tarasow TM; Clinical Trials Office, University of Illinois Cancer Center, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Hergenrother PJ; Department of Oncology, Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.
  • Dudek AZ; Vanquish Oncology, Inc., Champaign, Illinois, USA.
  • Danciu OC; Institute for Genomic Biology, University of Illinois, Urbana-Champaign, Illinois, USA.
Neurooncol Adv ; 5(1): vdad087, 2023.
Article en En | MEDLINE | ID: mdl-37554223
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Neurooncol Adv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Neurooncol Adv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido